C
EVH icon

Covestor’s Evolent Health EVH Stock Holding History

Covestor’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13K Buy
2,504
+336
+15% +$1.29K 0.01% 1366
2026
Q1 		$5K Buy
2,168
+2,162
+36,033% +$6.86K ﹤0.01% 1794
2025
Q4 		$0 Hold
6
– – ﹤0.01% 2385
2025
Q3 		$0 Hold
6
– – ﹤0.01% 2413
2025
Q2 		$0 Sell
6
-889
-99% -$8.16K ﹤0.01% 2352
2025
Q1 		$8K Buy
895
+87
+11% +$879 0.01% 1612
2024
Q4 		$9K Sell
808
-616
-43% -$10.8K 0.01% 1588
2024
Q3 		$40K Buy
1,424
+826
+138% +$21.3K 0.03% 951
2024
Q2 		$11K Buy
598
+593
+11,860% +$15.1K 0.01% 1460
2024
Q1 		$0 Hold
5
– – ﹤0.01% 2371
2023
Q4 		$0 Sell
5
-1
-17% -$28 ﹤0.01% 2286
2023
Q3 		$0 Sell
6
-1,481
-100% -$41.2K ﹤0.01% 2262
2023
Q2 		$45K Sell
1,487
-207
-12% -$6.69K 0.03% 824
2023
Q1 		$55K Buy
1,694
+1,194
+239% +$37.8K 0.05% 672
2022
Q4 		$14K Buy
500
+493
+7,043% +$14.1K 0.01% 1161
2022
Q3 		$0 Sell
7
-4
-36% -$141 ﹤0.01% 2149
2022
Q2 		$0 Sell
11
-8
-42% -$233 ﹤0.01% 2041
2022
Q1 		$1K Sell
19
-5
-21% -$131 ﹤0.01% 1793
2021
Q4 		$1K Buy
+24
New +$688 ﹤0.01% 1733

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Covestor's EVH Position: Q2 2026 in Review

Covestor increased its Evolent Health (EVH) stake by 15% in Q2 2026, buying an estimated $1.29K and bringing the position to 2,504 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #1366.

Covestor first reported a position in EVH in Q4 2021 and has held it in 19 quarters since. The position peaked at $55K in Q1 2023. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Covestor held 2,504 shares of Evolent Health worth $13K as of Q2 2026.
  • Covestor bought 336 Evolent Health shares in Q2 2026, an estimated $1.29K.
  • Evolent Health made up 0.01% of Covestor's portfolio in Q2 2026, its #1366 holding.
  • Covestor first reported a position in Evolent Health in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Evolent Health position peaked at $55K in Q1 2023.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.